全球造影注射器市场规模、份额、趋势和成长分析报告（2026-2034年）

造影剂注射器市场规模预计将从 2025 年的 28.8 亿美元成长到 2034 年的 74.9 亿美元，预计从 2026 年到 2034 年将以 11.21% 的复合年增长率成长。

由于电脑断层扫描（CT）、磁振造影（MRI）和血管造影术等医学影像技术的日益普及，全球造影剂注射器市场正经历稳定成长。造影剂注射器是一种用于在影像检查过程中将造影剂注入体内，以增强血管和内臟器官显影效果的装置。

慢性病盛行率的上升和对精准诊断影像需求的日益增长是市场成长的主要驱动力。医院和诊断中心越来越多地采用自动造影剂注射器，以确保剂量精准并提高病患安全。技术进步也推动了双头注射器和先进监测系统的发展。

随着诊断成像技术在全球范围内的日益普及，预计市场将持续成长。新兴国家医疗保健投资的增加和诊断成像设施的扩建将创造新的成长机会。注射器技术和诊断影像系统的持续创新将支撑造影剂注射器市场的长期发展。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球造影剂注射器市场：依产品划分

• 市场分析、洞察与预测
• 注射系统
• 消耗品

第五章 全球造影剂注射器市场：按类型划分

• 市场分析、洞察与预测
• 单头喷油器
• 双头喷油器
• 无针注射器

第六章 全球造影剂注射器市场：依应用划分

• 市场分析、洞察与预测
• 放射诊断
• 介入性心臟病学
• 介入放射学

第七章：全球造影剂注射器市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 诊断中心
• 门诊手术中心

第八章 全球造影剂注射器市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Shenzhen Boon Medical Supply Co. Ltd
  • Bayer
  • Bracco Diagnostics Inc
  • Ulrich GmbH & Co. KG
  • Guerbet LLC
  • B.Braun SE
  • Shenzhen Antmed Co. Ltd
  • Ecomed Solutions
  • Siemens Medical Solutions USA Inc
  • Nemoto Kyorindo Co. Ltd
  • Medtron AG

The Contrast Media Injectors Market size is expected to reach USD 7.49 Billion in 2034 from USD 2.88 Billion (2025) growing at a CAGR of 11.21% during 2026-2034.

The global contrast media injectors market is experiencing steady growth due to the increasing use of medical imaging procedures such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography. Contrast media injectors are devices used to deliver contrast agents into the body during imaging procedures to improve the visibility of blood vessels and internal organs.

The rising prevalence of chronic diseases and the growing demand for accurate diagnostic imaging are key factors driving market growth. Hospitals and diagnostic centers are increasingly adopting automated contrast media injectors that ensure precise dosing and improve patient safety. Technological advancements are also leading to the development of dual-head injectors and advanced monitoring systems.

Looking ahead, the market is expected to expand as diagnostic imaging procedures become more common worldwide. Increasing healthcare investments and the expansion of diagnostic imaging facilities in emerging economies will create new growth opportunities. Continuous innovation in injector technologies and imaging systems will support the long-term development of the contrast media injectors market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Injector Systems
• Consumables

By Type

• Single Head Injectors
• Dual-Head Injectors
• Syringeless Injectors

By Application

• Radiology
• Interventional Cardiology
• Interventional Radiology

By End Use

• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers

COMPANIES PROFILED

• Shenzhen Boon Medical Supply Co Ltd, Bayer, Bracco Diagnostics Inc, ulrich GmbH Co KG, Guerbet LLC, BBraun SE, Shenzhen Antmed Co Ltd, Ecomed Solutions, Siemens Medical Solutions USA Inc, Nemoto Kyorindo Co Ltd, Medtron AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CONTRAST MEDIA INJECTORS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Injector Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CONTRAST MEDIA INJECTORS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Single Head Injectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Dual-Head Injectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Syringeless Injectors Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CONTRAST MEDIA INJECTORS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Radiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Interventional Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Interventional Radiology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CONTRAST MEDIA INJECTORS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CONTRAST MEDIA INJECTORS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Type
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Type
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Type
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Type
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Type
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CONTRAST MEDIA INJECTORS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Shenzhen Boon Medical Supply Co. Ltd
  • 10.2.2 Bayer
  • 10.2.3 Bracco Diagnostics Inc
  • 10.2.4 Ulrich GmbH & Co. KG
  • 10.2.5 Guerbet LLC
  • 10.2.6 B.Braun SE
  • 10.2.7 Shenzhen Antmed Co. Ltd
  • 10.2.8 Ecomed Solutions
  • 10.2.9 Siemens Medical Solutions USA Inc
  • 10.2.10 Nemoto Kyorindo Co. Ltd
  • 10.2.11 Medtron AG